GenProbe Inc  (GPRO) Trade Now »     Rate GPRO  -  Discuss GPRO  -  Add to Watch List        

"Gen-Probe Incorporated (NASDAQ: GPRO) creates nucleic acid tests that identify disease-causing agents directly through their genetic fingerprints," says Dave Dyer.

In his Dave Dyer's Newsletter, he explains "The firm's most established market is screening donated blood for HIV and hepatitis viruses. Now, we expect it to be the first to have a gene-based test to detect prostate cancer."

"The current PSA test for prostate cancer --  the most common cancer in men -- is unreliable, in part, because a lot of things other than cancer can affect PSA levels. In addition, men dread the current testi